305 related articles for article (PubMed ID: 17018604)
1. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.
Dumaz N; Hayward R; Martin J; Ogilvie L; Hedley D; Curtin JA; Bastian BC; Springer C; Marais R
Cancer Res; 2006 Oct; 66(19):9483-91. PubMed ID: 17018604
[TBL] [Abstract][Full Text] [Related]
2. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.
Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL
Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890
[TBL] [Abstract][Full Text] [Related]
3. ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.
Marquette A; André J; Bagot M; Bensussan A; Dumaz N
Nat Struct Mol Biol; 2011 May; 18(5):584-91. PubMed ID: 21478863
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
Wellbrock C; Marais R
J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
[TBL] [Abstract][Full Text] [Related]
5. V599EB-RAF is an oncogene in melanocytes.
Wellbrock C; Ogilvie L; Hedley D; Karasarides M; Martin J; Niculescu-Duvaz D; Springer CJ; Marais R
Cancer Res; 2004 Apr; 64(7):2338-42. PubMed ID: 15059882
[TBL] [Abstract][Full Text] [Related]
6. BRAF, HRAS, KRAS, NRAS and CDKN2A genes analysis in cultured melanocytes used for vitiligo treatment.
Czajkowski R
Int J Dermatol; 2011 Feb; 50(2):180-3. PubMed ID: 21244382
[TBL] [Abstract][Full Text] [Related]
7. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
[TBL] [Abstract][Full Text] [Related]
8. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
Omholt K; Platz A; Kanter L; Ringborg U; Hansson J
Clin Cancer Res; 2003 Dec; 9(17):6483-8. PubMed ID: 14695152
[TBL] [Abstract][Full Text] [Related]
9. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
10. BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins.
Friday BB; Yu C; Dy GK; Smith PD; Wang L; Thibodeau SN; Adjei AA
Cancer Res; 2008 Aug; 68(15):6145-53. PubMed ID: 18676837
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
Yeh AH; Bohula EA; Macaulay VM
Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
Bellei B; Pitisci A; Catricalà C; Larue L; Picardo M
Pigment Cell Melanoma Res; 2011 Apr; 24(2):309-25. PubMed ID: 21040502
[TBL] [Abstract][Full Text] [Related]
13. Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.
Lissitzky JC; Parriaux D; Ristorcelli E; Vérine A; Lombardo D; Verrando P
Cancer Res; 2009 Feb; 69(3):802-9. PubMed ID: 19176384
[TBL] [Abstract][Full Text] [Related]
14. B-RAF: A contributor to the melanoma phenotype.
Heath EM; Kaufman KL; Christopherson RI
Int J Biochem Cell Biol; 2011 Jan; 43(1):29-32. PubMed ID: 20883818
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of RAF isoform switching induced by oncogenic RAS in melanoma.
Dumaz N
Small GTPases; 2011 Sep; 2(5):289-292. PubMed ID: 22292133
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells.
Lee JT; Steelman LS; McCubrey JA
Int J Oncol; 2005 Jun; 26(6):1637-44. PubMed ID: 15870880
[TBL] [Abstract][Full Text] [Related]
17. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes.
Buscà R; Abbe P; Mantoux F; Aberdam E; Peyssonnaux C; Eychène A; Ortonne JP; Ballotti R
EMBO J; 2000 Jun; 19(12):2900-10. PubMed ID: 10856235
[TBL] [Abstract][Full Text] [Related]
18. B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells.
Cui Y; Guadagno TM
Oncogene; 2008 May; 27(22):3122-33. PubMed ID: 18071315
[TBL] [Abstract][Full Text] [Related]
19. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).
Karreth FA; DeNicola GM; Winter SP; Tuveson DA
Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of (V600E)BRAF and the PI3K/AKT/mTOR pathway cooperates to induce apoptosis in melanoma cells through a MEK-independent mechanism.
Sánchez-Hernández I; Baquero P; Calleros L; Chiloeches A
Cancer Lett; 2012 Jan; 314(2):244-55. PubMed ID: 22056813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
